Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Non-Invasive Prenatal Testing (NIPT) Market: By Product and Service: Products, Services; By Method: Ultrasound Detection, Biochemical Screening Tests, Others; By Application; By End User; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Non-Invasive Prenatal Testing (NIPT) Market Outlook

The global non-invasive prenatal testing (NIPT) market attained a value of about USD 1.74 billion in 2021. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 14.30% to reach nearly USD 3.88 billion by 2027.

 

Global Non Invasive Prenatal Testing Nipt Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America Represents a Considerable Share of the Market for Non-Invasive Prenatal Testing (NIPT)

North America holds a significant share of the non-invasive prenatal testing industry. This can be attributed to the high preterm birth rate, the robust healthcare infrastructure, and the rising maternal mortality rate. The increasing incidences of chromosomal abnormalities and the rising awareness regarding the benefits of non-invasive prenatal testing (NIPT) are propelling the growth of the market. With the rising focus of the leading companies on expanding their offerings of non-invasive prenatal testing (NIPT), their demand is witnessing robust growth and fuelling the market growth.

As major insurance companies are adding NIPT in coverage plans, their surging demand is anticipated to boost the market growth. Further, the introduction of new and technologically advanced tests is significantly contributing to the growth of the market in this region. Meanwhile, the Asia Pacific region is expected to grow significantly owing to the developing healthcare infrastructure in emerging countries such as China and India, among others. The increasing public healthcare expenditure and the rising awareness regarding non-invasive prenatal testing (NIPT) are anticipated to invigorate the market growth. Moreover, technological advancements and innovations in non-invasive prenatal testing (NIPT) are estimated to propel the market growth in the forecast period.

 

Non-invasive Prenatal Testing (NIPT): Market Segmentation

Non-invasive prenatal testing (NIPT), also known as non-invasive prenatal screening (NIPS), is a method of analysing the risk of genetic abnormalities in foetus. It is a safe and highly effective method of screening the conditions for Down syndrome, Edwards syndrome, Patau syndrome, and Turner syndrome, among others. This is generally done by analysing small fragments of DNA, circulating in pregnant women’s blood by 10 weeks of pregnancy.

 

Global Non Invasive Prenatal Testing Nipt Market By Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on products and services, the market can be classified into:

  • Products
  • Services

The product segment is further bifurcated into consumables and instruments.

The major methods of non-invasive prenatal testing (NIPT) are:

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-Free DNA in Maternal Plasma Tests

The market can be broadly categorised on the basis of its applications into:

  • Trisomy
  • Microdeletion Syndrome
  • Others

On the basis of end user, the market can be segmented into:

  • Diagnostic Laboratories
  • Hospitals

The EMR report looks into the regional markets of non-invasive prenatal testing (NIPT) like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Non Invasive Prenatal Testing Nipt Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

High risk of Chromosomal Abnormalities Driving the Market Growth of Non-Invasive Prenatal Testing (NIPT)

The high risk of chromosomal abnormalities and the increasing maternal age are propelling the growth of non-invasive prenatal testing industry. As pregnancy above 35 years has a higher risk of genetic abnormalities, the demand for non-invasive prenatal testing (NIPT) is increasing. Obstetricians are increasingly recommending patients to undergo non-invasive tests to ensure healthy delivery of babies, hence fuelling the industry growth. Furthermore, the increasing research activities for the development of advanced technologies for NIPT are projected to propel the market growth. With technological advancements, the cost-effectiveness of non-invasive prenatal testing (NIPT) is increasing, which is estimated to bolster the market growth in upcoming years.

The increasing government spending on research and development (R&D) activities on non-invasive prenatal testing (NIPT) is expected to drive the market growth. Various laboratories and companies are providing advanced non-invasive prenatal testing (NIFT) to patients, which is propelling the growth of non-invasive prenatal testing industry. Moreover, the growing incidences of genetic disorders and the increasing public healthcare expenditure and growing awareness are estimated to propel the market growth in the forecast period.

 

Key Industry Players in the Global Non-Invasive Prenatal Testing (NIPT) Market

The report presents a detailed analysis of the following key players in the global non-invasive prenatal testing (NIPT) market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Illumina, Inc.
  • Thermo Fisher Scientific Corporation
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product and Service, Method, Application, End User, Region
Breakup by Product and Service Products, Services
Breakup by Method Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests
Breakup by Application Trisomy, Microdeletion Syndrome, Others
Breakup by End User Diagnostic Laboratories, Hospitals
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Illumina, Inc., Thermo Fisher Scientific Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Non-Invasive Prenatal Testing (NIPT) Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Non-Invasive Prenatal Testing (NIPT) Historical Market (2018-2022) 
    8.3    Global Non-Invasive Prenatal Testing (NIPT) Market Forecast (2023-2028)
    8.4    Global Non-Invasive Prenatal Testing (NIPT) Market by Product and Service
        8.4.1    Products
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Consumables 
                8.4.1.4.2    Instruments
        8.4.2    Services
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
    8.5    Global Non-Invasive Prenatal Testing (NIPT) Market by Method
        8.5.1    Ultrasound Detection
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Biochemical Screening Tests
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Cell-Free DNA in Maternal Plasma Tests
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
    8.6    Global Non-Invasive Prenatal Testing (NIPT) Market by Application
        8.6.1    Trisomy
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Microdeletion Syndrome
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Others
    8.7    Global Non-Invasive Prenatal Testing (NIPT) Market by End User
        8.7.1    Diagnostic Laboratories
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022)
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Hospitals
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022)
            8.7.2.3    Forecast Trend (2023-2028)
    8.8    Global Non-Invasive Prenatal Testing (NIPT) Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2018-2022)
        9.1.2    Forecast Trend (2023-2028)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2018-2022)
        9.2.2    Forecast Trend (2023-2028)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2018-2022)
        9.3.2    Forecast Trend (2023-2028)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2018-2022)
        9.4.2    Forecast Trend (2023-2028)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2018-2022)
        9.5.2    Forecast Trend (2023-2028)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Illumina, Inc.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Thermo Fisher Scientific Corporation
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    PerkinElmer, Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Agilent Technologies, Inc.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    F. Hoffmann-La Roche AG
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Non-Invasive Prenatal Testing (NIPT) Market: Key Industry Highlights, 2018 and 2028
2.    Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Product and Service (USD Billion), 2018-2022
3.    Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Product and Service (USD Billion), 2023-2028
4.    Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Method (USD Billion), 2018-2022
5.    Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Method (USD Billion), 2023-2028
6.    Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Application (USD Billion), 2018-2022
7.    Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Application (USD Billion), 2023-2028
8.    Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by End User (USD Billion), 2018-2022
9.    Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by End User (USD Billion), 2023-2028
10.    Global Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Region (USD Billion), 2018-2022
11.    Global Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Region (USD Billion), 2023-2028
12.    North America Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2022
13.    North America Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2023-2028
14.    Europe Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    Europe Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Asia Pacific Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Latin America Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2022
19.    Latin America Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2023-2028
20.    Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Historical Market: Breakup by Country (USD Billion), 2018-2022
21.    Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Forecast: Breakup by Country (USD Billion), 2023-2028
22.    Global Non-Invasive Prenatal Testing (NIPT) Market Structure

Key Questions Answered in the Report

In 2021, the global non-invasive prenatal testing (NIPT) market attained a value of nearly USD 1.74 billion.

The market is projected to grow at a CAGR of 14.30% between 2023 and 2028.

The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 3.88 billion by 2027.

The increasing incidence of chromosomal abnormalities and the increasing maternal age are driving the growth of non-invasive prenatal testing industry.

The industry is expected to be propelled by the rising incidences of genetic disorders, the increasing government spendings on research and development (R&D) activities, and technological advancements.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant products and services of non-invasive prenatal testing (NIPT) are products and services.

Ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests are the major methods of non-invasive prenatal testing (NIPT) in the industry.

The various applications of non-invasive prenatal testing (NIPT) are trisomy and microdeletion syndrome, among others.

Diagnostic laboratories and hospitals are different end users of non-invasive prenatal testing (NIPT).

The major players in the industry are Illumina, Inc., Thermo Fisher Scientific Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., and F. Hoffmann-La Roche AG, among others.

Analyst Review

The global non-invasive prenatal testing (NIPT) market attained a value of about USD 1.74 billion in 2021, driven by the rising incidence of chromosomal abnormalities. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 14.30%. The market is projected to reach nearly USD 3.88 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By product and service, the non-invasive prenatal testing (NIPT) industry can be bifurcated into products and services. On the basis of method, the market is classified into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. Based on its application, the market can be segmented into trisomy and microdeletion syndrome, among others. On the basis of end users, the market is divided into diagnostic laboratories and hospitals. The major regional markets for non-invasive prenatal testing (NIPT) are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Illumina, Inc., Thermo Fisher Scientific Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., and F. Hoffmann-La Roche AG, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER